Page last updated: 2024-08-22

trilostane and Atypical Ductal Hyperplasia

trilostane has been researched along with Atypical Ductal Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, YC; Chen, CK; Chen, MJ; Chen, SN; Cheng, SP; Huang, WC; Lin, CH; Lin, JC; Liu, CL	1

Other Studies

1 other study(ies) available for trilostane and Atypical Ductal Hyperplasia

Article	Year
Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status. Annals of surgical oncology, 2017, Volume: 24, Issue:13 Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Cycle; Cell Movement; Cell Proliferation; Dihydrotestosterone; Female; Follow-Up Studies; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Multienzyme Complexes; Progesterone Reductase; Prognosis; Receptors, Estrogen; RNA, Small Interfering; Steroid Isomerases; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2017

Article

Year

Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status.

Annals of surgical oncology, 2017, Volume: 24, Issue:13

Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Cycle; Cell Movement; Cell Proliferation; Dihydrotestosterone; Female; Follow-Up Studies; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Multienzyme Complexes; Progesterone Reductase; Prognosis; Receptors, Estrogen; RNA, Small Interfering; Steroid Isomerases; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2017